Articles written by the author
FDA Panel Splits on Whether to Approve New Diabetes Drug
An advisory panel for the Food and Drug Administration split evenly Thursday over whether the agency should approve the first oral medication to treat Type 1 diabetes.Trump to Pick Cancer Researcher to Head FDA
President Donald Trump said Friday that he intended to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration.
Trump to Nominate Stephen Hahn, Cancer Researcher, to Head FDA
President Donald Trump said Friday that he intended to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration.
Stephen Hahn, a Noted Cancer Researcher, to Be Nominated to Head the FDA
President Donald Trump was expected Friday to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a source familiar with the president’s decision.
Rules Would Allow Import of Some Cheaper Prescription Drugs, but With Limits
The Trump administration said Wednesday it was taking steps to make it easier to import less expensive prescription drugs from other countries, particularly Canada. The move has long been supported by progressives, but has encountered fierce opposition from the pharmaceutical industry.
Trump Administration Weighs Allowing Drug Imports for Cheaper Prescriptions
The Trump administration said Wednesday that it was taking steps to make it easier for less expensive prescription drugs to be imported from other countries, particularly Canada, a move that has long been supported by progressives but has encountered fierce opposition from the pharmaceutical industry.
Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.
Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.
Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.We Tried Five Polar-Weather Experiments. Here's What Happened.
EVANSTON, Ill. — It was minus 15 degrees here on Wednesday afternoon, near the epicenter of the polar vortex, and school had been canceled for much of the week.
Dr. John Mendelsohn, 82, Researcher Who Led Top Cancer Center, Dies
Dr. John Mendelsohn, who led the prestigious University of Texas MD Anderson Cancer Center through an era of substantial growth, and who, as a scientist, helped pioneer a new type of cancer therapy, died Jan. 7 at his home in Houston. He was 82.
FDA Panel Splits on Whether to Approve New Diabetes Drug
An advisory panel for the Food and Drug Administration split evenly Thursday over whether the agency should approve the first oral medication to treat Type 1 diabetes.FDA panel splits on whether to approve new diabetes drug
The committee voted 8-8, leaving it up to the agency to decide by the end of March whether the drug, sotagliflozin, should reach the market.
FDA panel splits on whether to approve new diabetes drug
The committee voted 8-8, leaving it up to the agency to decide by the end of March whether the drug, sotagliflozin, should reach the market.
